Healthcare AI 2025

FRANCE Law and Practice Contributed by: Liliana Eskenazi, Julie Ernewein and Pauline Lecrenais, Fréget Glaser et Associés

Fréget Glaser et Associés has, since its inception in 2014, continuously grown to become a solidly estab - lished and well-reputed high-end practice in the field of competition and regulation, with extensive exper - tise in the pharmaceuticals/life sciences sectors. The firm’s primary differentiator with respect to other law firms, particularly those driven by their corporate de - partments, is its ability to propose complex litigation

strategies with respect to all civil, commercial and administrative courts, as well as the regulatory au - thorities, rounding out clients’ overall business strat - egies. The keys to Fréget Glaser et Associés’ suc - cess lie not only in the cutting-edge legal expertise of its team members but in its ability to combine legal and economic expertise with out-of-the-box-thinking solutions.

Authors

Liliana Eskenazi is a partner at Fréget Glaser et Associés and an accomplished EU and competition/ antitrust lawyer with extensive experience in both advisory work and litigation. She handles complex cases

Julie Ernewein is a senior associate at Fréget Glaser & Associés and advises clients on matters relating to

economic and competition law, notably assisting companies in regulated industries, including within the life sciences sector. She also represents French and international clients in competition and commercial litigation, including private enforcement actions. Before joining the firm, Julie spent more than six years as part of the competition team of a top-tier international law firm. She has extensive experience in investigations conducted by French administration (DGCCRF/DDPP), the French Competition Authority, and the European Commission, as well as in litigation involving antitrust issues, restrictive practices and consumer protection law.

before the EU and the French courts, as well as before the administrative authorities (European Commission, French Competition Authority). Well- versed in all antitrust and distribution law matters, Liliana also handles multi-jurisdictional merger control cases within the context of corporate transactions. She acquired significant experience in regulated sectors (pharma, energy, telecoms), as well as in matters related to the interaction between intellectual property law and competition law.

Pauline Lecrenais is an associate and at Fréget Glaser & Associés specialised in competition law and regulated sectors, with a strong focus on the healthcare and digital industries. She represents French and

international companies, including major pharmaceutical laboratories, in high-stakes competition and private enforcement cases before the French and European courts and the French Competition Authority.

66

CHAMBERS.COM

Powered by